CRM
Salesforce.com Inc
Salesforce.com Inc historical holders
total: 22
Oakmark Select Fund Salesforce.com Inc transactions over time
- Total transactions:
- 15
- New positions:
- 2
- Sold out:
- 1
- Added:
- 7
- Reduced:
- 5
- Held since:
- 2025 Q2
- Held for:
- 4 quarters
- Latest activity:
- 2026 Q1
Bill Nygren has been an institutional investor in Salesforce.com Inc (CRM) since 2022 Q3. According to 2026 Q1 report, Bill Nygren holds 2,957,000 shares with a market value of roughly $551.98M representing 7.30% of their equity portfolio. The fund/company first acquired CRM in 2022 Q3, initially purchasing about 1.20M shares. Bill Nygren later completely sold out the position and reinvested in CRM again in 2025 Q2. Since the initial investment, Oakmark Select Fund has made 14 more transactions in this position.
Does Bill Nygren still hold CRM?
Yes, Bill Nygren continues to hold Salesforce.com Inc (CRM). According to their 2026 Q1 report, they maintain a position of 2,957,000 shares valued at approximately $551.98M, representing 7.30% of their equity portfolio.
When did Bill Nygren first invest in CRM?
Bill Nygren first invested in Salesforce.com Inc (CRM) in 2022 Q3 at the reported quarter-end price of $143.84 per share, acquiring 1,205,000 shares in their initial purchase.
What is Bill Nygren's average cost basis for CRM?
Based on historical transaction data, Bill Nygren's estimated cost basis for Salesforce.com Inc (CRM) is approximately $231.83 per share. This represents their average reported price* across all buy transactions.
Has Bill Nygren reinvested in CRM after selling?
Yes, Bill Nygren has shown renewed interest in Salesforce.com Inc (CRM). After completely selling their position, they reinitiated an investment in 2025 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $231.82
CRM transactions history by Oakmark Select Fund
15 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
7.30%
|
2,957,000
|
$186.67
|
$551,983,190
|
+62.74% (+1,140,000)
|
+2.81%
|
|
2025 Q4
|
5.89%
|
1,817,000
|
$264.91
|
$481,341,470
|
+18.60% (+285,000)
|
+0.92%
|
|
2025 Q3
|
4.82%
|
1,532,000
|
$237.00
|
$363,084,000
|
+60.25% (+576,000)
|
+1.81%
|
|
2025 Q2
|
3.57%
|
956,000
|
$272.69
|
$260,691,640
|
new
|
+3.57%
|
|
2025 Q1
|
0.00%
|
0
|
$334.33
|
|
-100% (-706,300)
|
-3.34%
|
|
2024 Q4
|
3.34%
|
706,300
|
$334.33
|
$236,137,279
|
-42.46% (-521,100)
|
-2.61%
|
|
2024 Q3
|
5.03%
|
1,227,400
|
$273.71
|
$335,951,654
|
+10.74% (+119,000)
|
+0.49%
|
|
2024 Q2
|
4.64%
|
1,108,400
|
$257.10
|
$284,969,640
|
+52.17% (+380,000)
|
+1.59%
|
|
2024 Q1
|
3.33%
|
728,400
|
$301.18
|
$219,379,512
|
-14.65% (-125,000)
|
-0.61%
|
|
2023 Q4
|
3.65%
|
853,400
|
$263.14
|
$224,563,676
|
-33.54% (-430,700)
|
-2.12%
|
|
2023 Q3
|
4.87%
|
$202.78
|
+11.85% (+136,000)
|
|||
|
2023 Q2
|
4.52%
|
$211.26
|
-25.79% (-399,100)
|
|||
|
2023 Q1
|
6.47%
|
$199.78
|
-3.00% (-47,800)
|
|||
|
2022 Q4
|
4.93%
|
$132.59
|
+32.37% (+390,000)
|
|||
|
2022 Q3
|
4.09%
|
$143.84
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.